Arbutus Biopharma Corporation

8-K Terminated a material agreement; Director or officer change; Other events Jul 16, 2026 8-K Director or officer change; Shareholder vote results May 27, 2026 10-Q Quarter ended 2026-03-31 May 13, 2026 8-K Results of operations (earnings release) May 13, 2026 8-K Other events Apr 15, 2026 8-K Results of operations (earnings release) Mar 23, 2026 10-K Fiscal year ended 2025-12-31 Mar 23, 2026 8-K Entered a material agreement; Other events Mar 3, 2026 8-K Other events Feb 20, 2026 8-K Other events Feb 6, 2026 8-K Other events Jan 16, 2026 8-K Other events Dec 11, 2025 8-K Results of operations (earnings release); Other events Nov 13, 2025 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Other events Oct 7, 2025 8-K Other events Sep 10, 2025 10-Q Quarter ended 2025-06-30 Aug 6, 2025 8-K Results of operations (earnings release); Director or officer change; Other events Aug 6, 2025 8-K Terminated a material agreement; Other events Jun 25, 2025 8-K Shareholder vote results May 23, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 8-K Results of operations (earnings release) May 14, 2025 8-K Other events May 7, 2025 8-K Other events Apr 23, 2025 8-K Director or officer change; Other events Apr 3, 2025 10-K Fiscal year ended 2024-12-31 Mar 27, 2025 8-K Results of operations (earnings release) Mar 27, 2025 8-K Entered a material agreement; Other events Mar 3, 2025 8-K Director or officer change; Other events Feb 25, 2025 8-K Results of operations (earnings release); Other events Jan 13, 2025 8-K Other events Nov 15, 2024 10-Q Quarter ended 2024-09-30 Nov 6, 2024 8-K Results of operations (earnings release); Other events Nov 6, 2024 8-K Other events Oct 15, 2024 8-K Director or officer change Oct 11, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Regulation FD disclosure Aug 5, 2024 8-K Results of operations (earnings release); Other events Aug 1, 2024 8-K Other events Jun 6, 2024 8-K Other events Jun 5, 2024